Alle Storys
Folgen
Keine Story von Marseille-Kliniken AG mehr verpassen.

Marseille-Kliniken AG

EANS-Adhoc: - Marseille-Kliniken AG appoints new member to Management Board

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
11.06.2010
Berlin, 11 June 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 
0007783003, MKA) has appointed Dr. Thomas Klaue (52) to the 
Management Board effective 1 July 2010. He is undertaking the role of
the Chief Financial Officer (CFO) and has also been appointed the 
Vice Chairman of the Management Board. This was resolved unanimously 
by the Supervisory Board in its meeting yesterday. The Management 
Board contract of Dr. Klaue has a term of three years.
Until April 2010, Dr. Klaue served as the CFO of MediGene AG, one of 
the leading German biotech companies based in Martinsried. Prior to 
that position, he worked in a number of executive roles at Infineon 
AG and Dasa.
Dr. Klaue is succeeding Claus Dobrowolski (53), who took over the 
role of interim CFO in April 2010. The Supervisory Board would like 
to thank Claus Dobrowolski for his valuable support.
End of ad hoc release
end of announcement                               euro adhoc

Further inquiry note:

Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.hillermann-consulting.de

Marseille-Kliniken AG
Dr. Ute Buchheim
Friedrich-Ebert-Str. 65
33330 Gütersloh
Germany
Tel.: +49-(0)5241 / 90 39-35
Fax: +49-(0)5241 / 90 39-39
www.marseille-kliniken.com

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hamburg / regulated dealing

Weitere Storys: Marseille-Kliniken AG
Weitere Storys: Marseille-Kliniken AG